17 December 2021>: Animal Study
Galangin Enhances Anticancer Efficacy of 5-Fluorouracil in Esophageal Cancer Cells and Xenografts Through NLR Family Pyrin Domain Containing 3 (NLRP3) Downregulation
Cong Zhang 1ABF* , Cui-Lian Luo 1BCD* , Guan-Sheng Shang 1DE , De-Xiong Jiang 1BF , Qi Song 2AG*DOI: 10.12659/MSM.931630
Med Sci Monit 2021; 27:e931630
Figure 2 Exponential effect curves of the combination of fluorouracil (5-FU) and galangin in Het-1A, Eca109, and OE19 cells for 48- or 72-h treatment. Each point is related to a combination index (CI) value of different combined treatment effects.